BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 10 Jul · 18:56 IST

Biocon Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon submitted a routine compliance certificate for the quarter ended June 30, 2025, as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations. The certificate, issued by KFin Technologies (the company's Registrar and Share Transfer Agent), confirms that all dematerialization and rematerialization requests received between April 1 and June 30, 2025, were processed within the 15-day deadline. It also confirms that physical share certificates were duly mutilated and cancelled, and that the depositories' names were updated in the register of members where applicable. No specific numbers on the volume of demat requests were disclosed. This is a standard quarterly procedural filing with no business or financial action involved.

Likely market impact

No material impact on shareholders or stock price. This is a routine regulatory compliance filing confirming proper handling of share dematerialization activities during the quarter.